Cash & equivalents decreased 24.5%
Cash & equivalents changed -24.5% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed -24.5% from the comparable as-filed period.
Net income changed -150.1% from the comparable as-filed period.
Operating income changed -154.3% from the comparable as-filed period.
Operating margin changed -13909 basis points from the comparable as-filed period.
Revenue changed -76.3% from the comparable as-filed period.
Stock-based compensation changed -12.2% from the comparable as-filed period.
Research & development changed -10.8% from the comparable as-filed period.
Inventory changed -2.3% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.